MetLife Preferreds Reviewed: Hold For Now
MetLife, Inc. offers three exchange-traded preferred stocks, providing investors with diversification beyond bank issuers. MET's strong financials, including a AA- S&P rating and net income 18x preferred dividends, support the safety of its preferred stock payouts. Among MET's preferreds, Series A offers the best current yield and floating rate protection in a rising rate environment, though all are callable.
MetLife Q3 Earnings Beat Estimates on Lower Costs, Asia Unit Strength
MET beats Q3 EPS estimates and rose 21% year over year as strong Asia results, attributable to higher volumes, and lower expenses offset Latin America tax hit.
MetLife, Inc. (MET) Q3 2025 Earnings Call Transcript
MetLife, Inc. ( MET ) Q3 2025 Earnings Call November 6, 2025 9:00 AM EST Company Participants John Hall - Senior VP & Head of Investor Relations Michel Khalaf - CEO, President & Director John McCallion - Executive VP, CFO & Head of Investment Management Lyndon Oliver - Regional President of Asia Ramy Tadros - Regional President of U.S. Business & Head of MetLife Holdings Chuck Davis Eric Sacha Clurfain - Regional President of Latin America Conference Call Participants Ryan Krueger - Keefe, Bruyette, & Woods, Inc., Research Division Thomas Gallagher - Evercore ISI Institutional Equities, Research Division Suneet Kamath - Jefferies LLC, Research Division Taylor Scott - Barclays Bank PLC, Research Division Wesley Carmichael - Autonomous Research US LP Joel Hurwitz - Dowling & Partners Securities, LLC Wilma Jackson Burdis - Raymond James & Associates, Inc., Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the MetLife Third Quarter 202 Earnings Conference Call.
MetLife to Report Q3 Earnings: What Do the Key Estimates Say?
MET is set to post Q3 results on Nov. 5, with estimates hinting at strong revenue and earnings growth despite cost pressures.
Insights Into MetLife (MET) Q3: Wall Street Projections for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for MetLife (MET), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2025.
MET Adds Cancer Support Benefit to Upgrade Critical Illness Plan
MetLife enhances its Critical Illness Insurance with a new Cancer Support benefit, offering enhanced care and guidance from Private Health Management experts for patients starting in 2026.
MetLife, Inc. (MET) Presents At KBW Insurance Conference 2025 Transcript
MetLife, Inc. (NYSE:MET ) KBW Insurance Conference 2025 September 3, 2025 10:05 AM EDT Company Participants Michel Khalaf - CEO, President & Director John McCallion - Executive VP, CFO & Head of Investment Management Conference Call Participants Ryan Krueger - Keefe, Bruyette, & Woods, Inc., Research Division Presentation Ryan Krueger Managing Director of Equity Research I'm Ryan Krueger, Life Insurance Analyst at KBW. It's great to have MetLife back with us again this year.
MetLife, Inc. (MET) Q2 2025 Earnings Call Transcript
MetLife, Inc. (NYSE:MET ) Q2 2025 Earnings Conference Call August 7, 2025 9:00 AM ET Company Participants Eric Sacha Stephane Clurfain - Regional President of Latin America John Arthur Hall - Senior VP & Head of Investor Relations John Dennis McCallion - Executive VP, CFO & Head of Investment Management Lyndon Oliver - Regional President of Asia Michel Abbas Khalaf - CEO, President & Director Ramy Tadros - Regional President of U.S. Business & Head of MetLife Holdings Conference Call Participants Cave Mohaghegh Montazeri - Deutsche Bank AG, Research Division Elyse Beth Greenspan - Wells Fargo Securities, LLC, Research Division Jamminder Singh Bhullar - JPMorgan Chase & Co, Research Division Joel Robert Hurwitz - Dowling & Partners Securities, LLC Ryan Joel Krueger - Keefe, Bruyette, & Woods, Inc., Research Division Suneet Laxman L. Kamath - Jefferies LLC, Research Division Thomas George Gallagher - Evercore ISI Institutional Equities, Research Division Wesley Collin Carmichael - Autonomous Research US LP Operator Ladies and gentlemen, thank you for standing by.
MetLife Q2 Earnings Lag Estimates on Soft MetLife Holdings Unit
MET misses on Q2 earnings as MetLife Holdings drags results. However, gains in EMEA and Latin America provide some relief.
Compared to Estimates, MetLife (MET) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for MetLife (MET) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
MetLife (MET) Q2 Earnings and Revenues Miss Estimates
MetLife (MET) came out with quarterly earnings of $2.02 per share, missing the Zacks Consensus Estimate of $2.19 per share. This compares to earnings of $2.28 per share a year ago.
MetLife to Report Q2 Earnings: What Do Key Estimates Say?
MET's Q2 results are likely to reflect gains from group benefits and Latin America profits. However, higher costs may weigh on results.
